This inventor holds 1 USPTO granted patent. Top assignee: Fred Hutchinson Cancer Center. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Chloe Slichter: Innovator in Immunomodulation
Introduction
Chloe Slichter is a prominent inventor based in Seattle, WA. She has made significant contributions to the field of immunology, particularly in the modulation of mucosal-associated invariant T (MAIT) cells. Her innovative work aims to enhance therapeutic strategies for conditions associated with inflammation.
Latest Patents
Chloe holds a patent titled "Systems and methods for immunomodulation of mucosal-associated invariant T cells." This patent describes systems and methods to modulate the function of MAIT cells in the absence of a T cell receptor (TCR) signal. The implications of her work are profound, as these systems can be utilized to elucidate the function of MAIT cells and assess potential therapeutic strategies for inflammatory conditions. She has 1 patent to her name.
Career Highlights
Chloe is currently affiliated with the Fred Hutchinson Cancer Center, where she continues her research and development in immunology. Her work is pivotal in advancing our understanding of immune responses and potential treatments for various inflammatory diseases.
Collaborations
Chloe collaborates with esteemed colleagues, including Julia Berkson and Martin Prlic. Their combined expertise enhances the research efforts at the Fred Hutchinson Cancer Center.
Conclusion
Chloe Slichter is a trailblazer in the field of immunomodulation, with her innovative patent contributing to the understanding of MAIT cells. Her work at the Fred Hutchinson Cancer Center exemplifies her commitment to advancing medical science and improving therapeutic strategies for inflammation-related conditions.